tiprankstipranks
Trending News
More News >
BeOne Medicines (ONC)
NASDAQ:ONC
US Market

BeOne Medicines (ONC) Ratios

Compare
859 Followers

BeOne Medicines Ratios

ONC's free cash flow for Q4 2025 was $0.90. For the 2025 fiscal year, ONC's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.41 3.41 1.80 2.32 3.55
Quick Ratio
3.08 3.08 1.58 2.09 3.35
Cash Ratio
2.51 2.49 1.19 1.75 2.63
Solvency Ratio
0.11 0.11 -0.18 -0.35 -0.97
Operating Cash Flow Ratio
0.62 0.62 -0.06 -0.64 -1.02
Short-Term Operating Cash Flow Coverage
19.82 8.37 -0.17 -1.68 -4.55
Net Current Asset Value
$ 2.39B$ 2.41B$ 1.40B$ 1.94B$ 3.21B
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.24 0.18 0.16 0.09
Debt-to-Equity Ratio
0.46 0.46 0.32 0.26 0.14
Debt-to-Capital Ratio
0.31 0.31 0.24 0.21 0.12
Long-Term Debt-to-Capital Ratio
0.29 0.29 0.05 0.05 0.05
Financial Leverage Ratio
1.89 1.88 1.78 1.64 1.46
Debt Service Coverage Ratio
5.40 2.52 -0.60 -1.71 -5.37
Interest Coverage Ratio
21.56 7.68 0.00 0.00 0.00
Debt to Market Cap
0.05 0.06 0.05 0.05 0.02
Interest Debt Per Share
1.40 18.87 10.26 8.91 5.79
Net Debt to EBITDA
-4.67 -4.13 3.90 2.00 1.90
Profitability Margins
Gross Profit Margin
86.91%87.49%84.41%84.55%79.77%
EBIT Margin
8.09%8.89%-14.91%-49.12%-126.40%
EBITDA Margin
10.32%11.54%-10.40%-45.55%-121.71%
Operating Profit Margin
8.38%8.37%-14.91%-49.12%-126.40%
Pretax Profit Margin
7.81%7.80%-13.99%-33.59%-138.50%
Net Profit Margin
5.37%5.37%-16.92%-35.86%-141.52%
Continuous Operations Profit Margin
5.37%5.37%-16.92%-35.86%-141.52%
Net Income Per EBT
68.71%68.83%120.97%106.77%102.18%
EBT Per EBIT
93.16%93.23%93.81%68.38%109.58%
Return on Assets (ROA)
3.50%3.50%-10.89%-15.19%-31.41%
Return on Equity (ROE)
7.31%6.58%-19.35%-24.93%-45.71%
Return on Capital Employed (ROCE)
7.03%7.03%-15.33%-30.23%-36.44%
Return on Invested Capital (ROIC)
4.77%4.74%-12.42%-25.67%-34.00%
Return on Tangible Assets
3.53%3.53%-11.13%-15.48%-31.88%
Earnings Yield
0.58%0.87%-3.32%-4.77%-8.83%
Efficiency Ratios
Receivables Turnover
6.05 6.18 5.37 6.21 7.12
Payables Turnover
1.47 1.40 1.47 1.21 0.97
Inventory Turnover
1.16 1.10 1.20 0.91 1.01
Fixed Asset Turnover
3.00 2.99 2.30 1.79 1.53
Asset Turnover
0.65 0.65 0.64 0.42 0.22
Working Capital Turnover Ratio
1.39 1.73 1.83 0.80 0.29
Cash Conversion Cycle
127.41 129.63 123.22 155.81 35.45
Days of Sales Outstanding
60.29 59.10 67.93 58.77 51.29
Days of Inventory Outstanding
315.99 332.07 304.11 399.78 359.74
Days of Payables Outstanding
248.87 261.54 248.82 302.74 375.58
Operating Cycle
376.29 391.17 372.04 458.55 411.03
Cash Flow Ratios
Operating Cash Flow Per Share
0.79 10.34 -1.34 -11.09 -14.51
Free Cash Flow Per Share
0.60 8.63 -6.36 -16.80 -19.06
CapEx Per Share
0.18 1.70 5.03 5.71 4.55
Free Cash Flow to Operating Cash Flow
0.77 0.84 4.76 1.52 1.31
Dividend Paid and CapEx Coverage Ratio
4.27 6.07 -0.27 -1.94 -3.19
Capital Expenditure Coverage Ratio
4.27 6.07 -0.27 -1.94 -3.19
Operating Cash Flow Coverage Ratio
0.57 0.56 -0.13 -1.24 -2.51
Operating Cash Flow to Sales Ratio
0.21 0.21 -0.04 -0.47 -1.06
Free Cash Flow Yield
2.42%2.84%-3.44%-9.49%-8.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
171.86 115.48 -30.16 -20.96 -11.32
Price-to-Sales (P/S) Ratio
6.70 6.20 5.10 7.51 16.02
Price-to-Book (P/B) Ratio
11.35 7.60 5.84 5.22 5.17
Price-to-Free Cash Flow (P/FCF) Ratio
41.33 35.18 -29.04 -10.54 -11.54
Price-to-Operating Cash Flow Ratio
43.55 29.39 -138.29 -15.96 -15.16
Price-to-Earnings Growth (PEG) Ratio
8.25 -0.18 1.09 0.37 -0.41
Price-to-Fair Value
11.35 7.60 5.84 5.22 5.17
Enterprise Value Multiple
60.27 49.59 -45.15 -14.49 -11.26
Enterprise Value
33.35B 30.59B 17.90B 16.23B 19.41B
EV to EBITDA
60.27 49.59 -45.15 -14.49 -11.26
EV to Sales
6.22 5.72 4.70 6.60 13.71
EV to Free Cash Flow
38.35 32.48 -26.73 -9.26 -9.87
EV to Operating Cash Flow
29.36 27.13 -127.28 -14.03 -12.97
Tangible Book Value Per Share
3.00 39.41 30.42 32.84 41.58
Shareholders’ Equity Per Share
3.03 39.99 31.65 33.89 42.50
Tax and Other Ratios
Effective Tax Rate
0.31 0.31 -0.21 -0.07 -0.02
Revenue Per Share
3.73 48.99 36.19 23.55 13.73
Net Income Per Share
0.20 2.63 -6.12 -8.45 -19.43
Tax Burden
0.69 0.69 1.21 1.07 1.02
Interest Burden
0.97 0.88 0.94 0.68 1.10
Research & Development to Revenue
0.40 0.40 0.51 0.72 1.16
SG&A to Revenue
0.10 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.07 0.10 0.12 0.15 0.21
Income Quality
3.95 3.93 0.22 1.31 0.75
Currency in USD